摘要
目的分析肺癌脑转移的治疗方法与患者预后的关系。方法整群选取该院105例肺癌脑转移患者,将其随机分为3组,对症治疗组、放疗组、放疗联合化疗组,每组35例,比较3组患者的生存时间和生存率。结果放疗联合化疗组的患者生存时间明显长于对症治疗组和放疗组(P<0.05),生存率也高于其他两组(P<0.05)。结论治疗肺癌脑转移时,放疗联合化疗具有较好的预后,患者的生存时间延长,生存率提高,因此值得临床的广泛应用。
Objective To analyze the relation between the treatment and prognosis of patients with brain metastases from lung cancer. Methods 105 cases of patients with brain metastases from lung cancer were selected and randomly divided into three groups, symptomatic treatment group, radiotherapy group, radiotherapy combined with chemotherapy group, with 35 patients in each group, Survival time and survival rate of the three groups were compared. Results The survival time of patients in radiation combined chemotherapy group was obviously longer than that in the symptomatic treatment group as well as radiotherapy group （P〈0.05）, and the survival rate of it was higher than that in the other two groups （P〈0.05）. Conclusion In the treatment of brain metastases from lung cancer, radiotherapy combined with chemotherapy is worthy of clinical extensive application for its good prognosis and prolonged survival time of patients and high survival rate.
出处
《中外医疗》
2015年第19期34-35,38,共3页
China & Foreign Medical Treatment
关键词
肺癌脑转移
治疗方法
预后
Brain metastases from lung cancer
Treatment
The prognosis
